Mesothelioma
Study Name: AZ eVOLVE Meso
- Cancer Stage: Unresectable
- Key Inclusion: Advanced, pleural
- Description: MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- Study Number: D7988C00001
- NCT#: NCT06097728